Dr. Jenica N. Upshaw, MD

Dr. Upshaw practices at Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine.

Dr. Upshaw's NPI, 1295994820, was assigned on June 9, 2008. Dr. Upshaw holds Massachusetts license 246798.

Dr. Upshaw's primary practice is Tufts Medical Center, at 800 Washington Street, Boston, MA 02111 in Suffolk County. The practice phone is (617) 636-5000.

Dr. Upshaw's primary practice is Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine. Dr. Upshaw is also affiliated with Brigham and Women's Hospital. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Upshaw to 2 more hospitals, 2 medical groups and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Upshaw practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Upshaw's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Upshaw is licensed in Massachusetts.

CMS data shows 764 Medicare services from Dr. Upshaw across 10 procedure codes in 2024, for 489 Medicare patients. Medicare paid $33,447 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 489 Medicare patients who saw Dr. Upshaw in 2024. The largest group is 65 to 74, with 189 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Upshaw's median patient age at 68, with 44% women.

In 2024, Dr. Upshaw wrote 674 Medicare Part D claims for 112 patients. 69% of them were for generic drugs. CMS names the drug for 567 of them, across 19 drugs with 11 or more claims each, at $203,929 in total drug cost. In 2023, CMS named 633 claims across 21 drugs.

Dr. Upshaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Upshaw as offering telehealth.

Dmand AI links 51 papers to Dr. Upshaw, published from 2014 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Heart Failure, Breast Neoplasms and Antineoplastic Combined Chemotherapy Protocols. Dr. Upshaw has published most often in JACC Case Rep. Dr. Upshaw's most frequent co-authors are Bonnie Ky, MD, Michael Kiernan, MD and David Denofrio, MD.

Dmand AI links Dr. Upshaw to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Fatigue, Heart Failure and Breast Neoplasms.

CMS Open Payments shows 16 general payments to Dr. Upshaw from 5 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 63% of the total. Merck Sharp & Dohme Corporation paid the most, $914.